ConnectiveRx, a patient and provider engagement company, has acquired pharmacy benefit platform The Macaluso Group (TMG).
This transaction, which was for an undisclosed amount, will increase ConnectiveRx’s buy and bill reimbursement services. It will also bolster its payment and customer support capabilities.
Through their combined buy and bill reimbursement platform and secure payment platform, ConnectiveRx will support patients and healthcare providers with payment and debit processing solutions.
Headquartered in New Jersey, TMG develops technology to support patients with access to payment solutions. The company’s solutions help to offer pharmacy benefits, reimbursement services, co-pay and financial assistance.
Its products include co-pay cards, guardian verification solutions, a TMG payment card, self-insured and savings cards, and professional insight platforms. The TMG payment card streamlines and expedites payments with automatic, real-time processing and verification.
Founded in 2015, US-based ConnectiveRx is a support platform for patients and medication. The platform helps 125 biopharmaceutical manufacturers to manage their patients and implement programs to ensure they start the medication and continue adherence.
TMG CEO and founder Joe Macaluso said, “We are pleased to integrate our reimbursement and payment support offerings with ConnectiveRx’s full suite of innovative adherence solutions. We have a common mission to offer our clients, providers and patients with an upgraded, reliable and simple experience and a seamless transition that we are proud to be part of.”
Last month, Affordplan netted $10m in its Series B round led by Lok Capital, to support the rising demand of its alternative finance solution for healthcare treatment.
Copyright © 2018 FinTech Global